Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Psychiatry
•
Behavioral Neurology & Neuropsychiatry
Is there sufficient evidence yet to support the use of lithium supplementation or prescription in the management of neurodegenerative diseases?
Would you consider it in a patient with strong familial risk of early onset NDD?
Related Questions
When do you consider using stimulants in patients with cognitive impairments secondary to traumatic brain injury?
How do you treat agitation in progressive supranuclear palsy?
What is your approach to Tardive Dyskinesia when VMAT2 inhibitors are ineffective or unaffordable?
What is your approach to determining eligibility for hospice in persons with Alzheimer's disease?
How do you manage problematic disinhibited behaviors in patients with neurocognitive disorders?
Are the laws regarding prescribing C-2 medications different for mail order pharmacies?
What approaches have you found most helpful for concurrent severe major depressive disorder and alcohol use disorder?
When do you attribute tremors to lamotrigine?
What pharmacological management do you consider in patients with Autism Spectrum Disorder whose primary behavior is aggression?
Are there specific tools that you request for an IEP of a child with dyslexia?